130 related articles for article (PubMed ID: 8657727)
21. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
23. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
[TBL] [Abstract][Full Text] [Related]
24. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
25. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
26. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
[TBL] [Abstract][Full Text] [Related]
27. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
29. In situ localization of S-phase-specific histone (H3) mRNA in Bowen's disease.
Murakami M; Mizoguchi Y; Horibe Y; Komori K; Hori H; Kasahara M
APMIS; 1999 Nov; 107(11):1005-12. PubMed ID: 10598872
[TBL] [Abstract][Full Text] [Related]
30. Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma.
Sistayanarain A; Tsuneyama K; Zheng H; Takahashi H; Nomoto K; Cheng C; Murai Y; Tanaka A; Takano Y
Anticancer Res; 2006; 26(5A):3585-93. PubMed ID: 17094487
[TBL] [Abstract][Full Text] [Related]
31. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
[TBL] [Abstract][Full Text] [Related]
32. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
[TBL] [Abstract][Full Text] [Related]
33. "Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade.
Zhao M; Laissue JA; Zimmermann A
Histol Histopathol; 1993 Oct; 8(4):617-26. PubMed ID: 8305816
[TBL] [Abstract][Full Text] [Related]
34. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
35. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
Liu SC; Sauter ER; Clapper ML; Feldman RS; Levin L; Chen SY; Yen TJ; Ross E; Engstrom PF; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):597-603. PubMed ID: 9681528
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
37. Down regulation of DRET gene in human hepatocellular carcinoma tissues samples from Qidong area, China.
Lu DD; Zhang XR
Eksp Onkol; 2004 Mar; 26(1):75-7. PubMed ID: 15112585
[TBL] [Abstract][Full Text] [Related]
38. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
Wu PC; Fang JW; Lau VK; Lai CL; Lo CK; Lau JY
Am J Pathol; 1996 Oct; 149(4):1167-75. PubMed ID: 8863666
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
